Keyword: Sun Pharmaceutical Industries

News

Sun Pharma Boosts Dermatology Offering with Concert Buy

24.01.2023 -

Indian drugmaker Sun Pharmaceutical Industries is to buy US biotech Concert Pharmaceuticals, gaining access to the latter’s lead product candidate deuruxolitinib for...

News

India’s Sun Pharmaceutical to Buy Compatriot Ranbaxy

09.04.2014 - Sun Pharmaceutical Industries, India's largest drugmaker by market value, has agreed to buy compatriot generics manufacturer Ranbaxy Laboratories for $3.2 billion from Daiichi...

News

Swedish Drugmaker Meda Spurns Mylan Approach

07.04.2014 - Swedish generic drugmaker Meda has rejected a takeover approach by U.S. rival Mylan to create a combined company worth around $24 billion. Reports said Mylan was exploring a bid at...

News

Teva, Sun Pharma to Pay $2.15 Billion to Settle Pfizer Patent Suit

12.06.2013 - Pfizer said Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries would pay $2.15 billion to settle a patent suit related to its acid-reflux drug. This is the first...

News

India's Sun Pharma Wins over Taro with Higher Offer

13.08.2012 - India's Sun Pharmaceutical Industries has upped the buy-out price for its Israeli unit Taro Pharma by 60%, winning over Taro's board and ending a long battle to gain full control...

News

U.S. Court Upholds Pfizer's Lyrica Patent Protection

19.07.2012 - Pfizer beat back a challenge from generic drugmakers to a patent that protects its pain medicine Lyrica, its second-best selling drug when a federal judge ruled in its favor on...

News

US Top Court Rules for Generic Drugmaker on Patent

18.04.2012 - The U.S. Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to...

News

Sun Pharma To Sell Some Merck Diabetes Drugs In India

27.04.2011 - Sun Pharmaceutical Industries has entered into a deal to market Merck & Co's diabetes drugs - sitagliptin and sitagliptin plus metformin - in India, the two drugmakers said in a...